Pharmafile Logo

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

With rapid growth comes growing pains…

- PMLiVE

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.

Specific challenges facing the oncology field

1. Increased competition and evolving standard of care

New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.

With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.

Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…

Read the full article here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Impetus Digital Fireside Chat with Ryan Wiley, President of Shift Health

Ryan Wiley, President of Shift Health, discusses healthcare's journey towards digitalization and the ramifications COVID-19 has had in many of these areas. We also talk about Ryan's shift from academia to consulting...

Impetus Digital Fireside Chat with Tom Hsu, VP, Specialty Medicine at Bayer Canada

Tom Hsu, VP of Specialty Medicine at Bayer Canada,  talks about how he got to where he is today and his experience working for Bayer in China, and how that compares to...

Impetus Digital Fireside Chat with MindSet

Ryan Zarychanski, Paul Komenda, and Marshall Pitz from MindSet, discuss a whole range of thought-provoking topics, including the barriers to and benefits of clinical data integration for the healthcare system, clinical trials, providers,...

Impetus Digital Fireside Chat with Stephany Lapierre, Founder and CEO of Tealbook

Stephany Lapierre, Founder and CEO of Tealbook sits down with us in this Fireside Chat. Stephany is a highly coveted supply chain thought-leader, and one of the most influential minds in...

Impetus Digital Fireside Chat with with Jon Sockell, Co-Founder/COO of Limbix

Jon Sockell, Co-founder and COO of Limbix, sits down with us in this Fireside Chat. See how Limbix is paving the way for prescription digital therapeutics and learn from their trials,...

Impetus Digital Systems Innovation Masterclass: Systems Change, Wicked Problems, and Multisolving

In this session, we discussed systems change, wicked problems, and multisolving. We reviewed the transformational changes that can evolve and go beyond "cause and effect" thinking. In this dialogue, we...

“Virtualizing” a Company Brand Planning Meeting: a Customer Story

Find out how Impetus Digital helped virtualize their client's internal brand planning session